Dogwood Therapeutics DWTX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$28.32M-28.8% | -$34.26M-177% | -$38.2M-567% | -$24.74M-429% | -$21.98M-334% | ||
| —— | —— | —— | $40.37K— | $26.15K— | ||
| $720.59K+70.9% | $355.64K-25.3% | $291.58K-45.0% | $337.61K-42.2% | $421.53K-29.4% | ||
| -$15.52M-23.8% | -$15.62M-77.7% | -$18.11M-339% | -$15.75M-277% | -$12.54M-205% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$4.32M-128% | -$8.33M-171% | $8.22M+399% | $10.52M+695% | $15.3M+586% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Dogwood Therapeutics generate?
- Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
- Where does Dogwood Therapeutics's cash flow data come from?
- Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.